Technology
Health
Biotechnology
Aldeyra Therapeutics
$4.869876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-0.82%) Today
$0.00 (0.00%) As of 4:25 PM EDT after-hours
Why Robinhood?
You can buy or sell ALDX and other stocks, options, ETFs, and crypto commission-free!
About ALDX
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. Read More The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Employees
19
Headquarters
Lexington, Massachusetts
Founded
2004
Market Cap
134.03M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
174.61K
High Today
$5.03
Low Today
$4.78
Open Price
$4.95
Volume
236.15K
52 Week High
$16.70
52 Week Low
$4.75
Collections
Technology
Health
Biotechnology
Therapy
2014 IPO
US
North America
ALDX News
Price Paid on Robinhood
45% Lower
Right Now
52 Week Low
$6.75
Average Price Paid
$8.90
52 Week High
$16.70
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
ALDX Earnings
-$0.52
-$0.46
-$0.39
-$0.33
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.49 per share
Actual
-$0.49 per share